{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T07:23:54Z","timestamp":1765005834626,"version":"3.46.0"},"reference-count":10,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2025,4,24]]},"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1136\/gutjnl-2025-334946","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T13:20:21Z","timestamp":1747142421000},"page":"1753.1-1755","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Withdrawal of antitumour necrosis factor in patients with inflammatory bowel disease in remission: a randomised placebo-controlled clinical trial of GETECCU"],"prefix":"10.1136","volume":"74","author":[{"given":"Jonathan","family":"Blackwell","sequence":"first","affiliation":[{"name":"The Edinburgh IBD Unit, NHS Lothian, Edinburgh, UK"},{"name":"Deanery of Molecular, Genetic & Population Health Sciences, University of Edinburgh Western General Hospital, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3229-8759","authenticated-orcid":false,"given":"Nikolas","family":"Plevris","sequence":"additional","affiliation":[{"name":"The Edinburgh IBD Unit, NHS Lothian, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Bancil","sequence":"additional","affiliation":[{"name":"Department of Nutritional Sciences, King\u2019s College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2073-4234","authenticated-orcid":false,"given":"Taku","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Center for Advanced IBD Research and Treatment, Kitasato Institute Hospital, Minato-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2855-3400","authenticated-orcid":false,"given":"Shahida","family":"Din","sequence":"additional","affiliation":[{"name":"The Edinburgh IBD Unit, NHS Lothian, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"2025120523211456000_74.10.1753.1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-333385"},{"key":"2025120523211456000_74.10.1753.2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S2468-1253(21)00062-5","article-title":"Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial","volume":"6","author":"Kobayashi","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025120523211456000_74.10.1753.3","doi-asserted-by":"crossref","unstructured":"Buhl S , Steenholdt C , Brynskov J , et al . Discontinuation of Infliximab Therapy in Patients with Crohn\u2019s Disease. NEJM Evid 2022;1. doi:10.1056\/EVIDoa2200061","DOI":"10.1056\/EVIDoa2200061"},{"key":"2025120523211456000_74.10.1753.4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S2468-1253(22)00385-5","article-title":"Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn\u2019s disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial","volume":"8","author":"Louis","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025120523211456000_74.10.1753.5","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.54"},{"key":"2025120523211456000_74.10.1753.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70140-5"},{"key":"2025120523211456000_74.10.1753.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.08.006"},{"key":"2025120523211456000_74.10.1753.8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0304851","article-title":"Reduction of biologic pricing following biosimilar introduction: analysis across 57 countries and regions, 2012-19","volume":"19","author":"Chen","year":"2024","journal-title":"PLoS ONE"},{"key":"2025120523211456000_74.10.1753.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.11.062"},{"key":"2025120523211456000_74.10.1753.10","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318484"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2025-334946","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T07:21:24Z","timestamp":1765005684000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2025-334946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":10,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,9,8]]},"published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1136\/gutjnl-2025-334946"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2025-334946","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"type":"print","value":"0017-5749"},{"type":"electronic","value":"1468-3288"}],"subject":[],"published":{"date-parts":[[2025,5,13]]}}}